- Home
- FOLD vs TR Comparison
FOLD vs TR Comparison
Compare FOLD & TR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- TR
- Stock Information
- Founded
- FOLD 2002
- TR 1896
- Country
- FOLD United States
- TR United States
- Employees
- FOLD N/A
- TR N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- TR Specialty Foods
- Sector
- FOLD Health Care
- TR Consumer Staples
- Exchange
- FOLD Nasdaq
- TR Nasdaq
- Market Cap
- FOLD 2.9B
- TR 2.5B
- IPO Year
- FOLD 2007
- TR N/A
- Fundamental
- Price
- FOLD $6.12
- TR $34.97
- Analyst Decision
- FOLD Buy
- TR
- Analyst Count
- FOLD 10
- TR 0
- Target Price
- FOLD $16.22
- TR N/A
- AVG Volume (30 Days)
- FOLD 5.5M
- TR 334.9K
- Earning Date
- FOLD 08-07-2025
- TR 08-07-2025
- Dividend Yield
- FOLD N/A
- TR 1.03%
- EPS Growth
- FOLD N/A
- TR N/A
- EPS
- FOLD N/A
- TR 1.21
- Revenue
- FOLD $543,141,000.00
- TR $718,497,000.00
- Revenue This Year
- FOLD $19.87
- TR N/A
- Revenue Next Year
- FOLD $23.15
- TR N/A
- P/E Ratio
- FOLD N/A
- TR $28.63
- Revenue Growth
- FOLD 28.25
- TR N/A
- 52 Week Low
- FOLD $5.51
- TR $26.78
- 52 Week High
- FOLD $12.65
- TR $36.25
- Technical
- Relative Strength Index (RSI)
- FOLD 51.42
- TR 55.53
- Support Level
- FOLD $5.66
- TR $33.67
- Resistance Level
- FOLD $6.45
- TR $35.71
- Average True Range (ATR)
- FOLD 0.21
- TR 0.91
- MACD
- FOLD 0.07
- TR 0.04
- Stochastic Oscillator
- FOLD 64.89
- TR 72.30
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.